Some patients who have heart attacks, that have stents placed in their coronary arteries, or undergo coronary artery bypass graft surgery (CABG) are treated with two types of antiplatelet agents at the same time to prevent blood clotting. This is called dual antiplatelet therapy (DAPT).

One antiplatelet agent is aspirin. Almost everyone with coronary artery disease, including those who have had a heart attack, stent, or CABG are treated with aspirin for the rest of their lives. A second type of antiplatelet agent, called a P2Y12 inhibitor, is usually prescribed for months or years in addition to the aspirin therapy.

The type of medication and the duration of your treatment will vary based on your condition and other risk factors. The risks and benefits of DAPT should be discussed with your health care provider

Our Journal welcomes submissions of manuscripts on the topics covering Atherosclerosis, Heart Attack, Ischemic Stroke, Cardiac ischemia, Plaque Attacks, Heart failure, Arrhythmia, Bradycardia, Tachycardia, Heart Valve problems, Angina, heart failure, etc. In the quality perspective, the journal is determined to maintain an exceptionally high standard in both facts and ethics. Accuracy and authenticity in the scientific reports of present journal are conserved above all nominal needs of the time.

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System or as an email attachment to cmt@emedsci.com

Best Regards,
Samuel G,
Editorial Manager,
Journal of Cardiovascular Medicine and Therapy